新兴癌症治疗时代的心房颤动 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Atrial Fibrillation in the Era of Emerging Cancer Therapies.新兴癌症治疗时代的心房颤动

Eur Heart J. 2019 Sep 21;40(36):3007-3010. doi: 10.1093/eurheartj/ehz649.

2

Stroke prevention in atrial fibrillation.心房颤动的卒中预防

Cardiovasc Drugs Ther. 2011 Dec;25(6):561-70. doi: 10.1007/s10557-011-6334-4.

3

Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review.心房颤动与恶性肿瘤：非维生素 K 口服抗凝剂的临床表现——系统评价。

Semin Thromb Hemost. 2019 Mar;45(2):205-214. doi: 10.1055/s-0038-1661386. Epub 2018 Aug 17.

4

Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target.心房颤动的抗凝治疗：最新进展及针对快速变化目标的建议。

Can J Cardiol. 2013 Jul;29(7 Suppl):S1-3. doi: 10.1016/j.cjca.2013.05.001.

5

[Anticoagulation in atrial fibrillation].[心房颤动的抗凝治疗]

Herz. 2008 Feb;33(1):13-9. doi: 10.1007/s00059-008-3090-8.

6

Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.出血是一种必要的恶吗？用于心房颤动卒中预防的抗栓药物治疗的内在风险。

Expert Rev Cardiovasc Ther. 2013 Aug;11(8):1029-49. doi: 10.1586/14779072.2013.815423.

7

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。

Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.

8

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.女性性别是心房颤动患者发生中风和血栓栓塞的一个危险因素。

Thromb Haemost. 2009 May;101(5):802-5.

9

Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.老年房颤患者在开始抗凝预防血栓栓塞时出血：每况愈下。

Circulation. 2007 May 29;115(21):2684-6. doi: 10.1161/CIRCULATIONAHA.107.704122.

10

Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal.观点：对近期心房颤动患者管理指南中卒中预防部分的评价。

Am J Med. 2017 Jul;130(7):773-779. doi: 10.1016/j.amjmed.2017.02.026. Epub 2017 Mar 24.

引用本文的文献

1

Atrial fibrillation and ischemic stroke in cancer: the latest scientific evidence, current management, and future directions.癌症中的心房颤动与缺血性卒中：最新科学证据、当前管理及未来方向

J Thromb Thrombolysis. 2025 Apr 26. doi: 10.1007/s11239-025-03104-3.

2

Selection of rhythm intervention strategies in atrial fibrillation patients with cancer and efficacy and safety of catheter ablation.癌症合并心房颤动患者节律干预策略的选择及导管消融的有效性与安全性

Front Cardiovasc Med. 2024 Nov 22;11:1506143. doi: 10.3389/fcvm.2024.1506143. eCollection 2024.

3

Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms.

癌症、抗癌疗法和潜在机制中的心房颤动。

J Mol Cell Cardiol. 2024 Sep;194:118-132. doi: 10.1016/j.yjmcc.2024.06.005. Epub 2024 Jun 17.

4

Atrial Fibrillation Catheter Ablation among Cancer Patients: Utilization Trends and In-Hospital Outcomes.癌症患者的心房颤动导管消融术：使用趋势和住院结局

J Clin Med. 2024 Feb 26;13(5):1318. doi: 10.3390/jcm13051318.

5

Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial fibrillation.接受导管消融治疗心房颤动的癌症患者的治疗结果和再入院情况。

Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad263.

6

Construction and validation of a nomogram of risk factors for new-onset atrial fibrillation in advanced lung cancer patients after non-surgical therapy.晚期肺癌患者非手术治疗后新发房颤危险因素列线图的构建与验证

Front Oncol. 2023 Jul 13;13:1125592. doi: 10.3389/fonc.2023.1125592. eCollection 2023.

7

Atrial fibrillation and breast cancer-Vicious twins? A systematic review and meta-analysis.心房颤动与乳腺癌——难兄难弟？一项系统评价与荟萃分析

Front Cardiovasc Med. 2023 Mar 10;10:1113231. doi: 10.3389/fcvm.2023.1113231. eCollection 2023.

8

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis.乳腺癌患者心房颤动的发生率、风险因素和死亡率：一项 SEER-Medicare 分析。

Eur Heart J. 2022 Jan 31;43(4):300-312. doi: 10.1093/eurheartj/ehab745.

9

ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).意大利心脏病学协会立场文件：新冠疫情时代的心衰与癌症共病（CO与CO）

Eur Heart J Suppl. 2021 Aug 26;23(Suppl C):C128-C153. doi: 10.1093/eurheartj/suab067. eCollection 2021 Aug.

10

Risk factors and survival analysis of arrhythmia following lung cancer surgery: a retrospective study.肺癌手术后心律失常的危险因素及生存分析：一项回顾性研究。

J Thorac Dis. 2021 Feb;13(2):847-860. doi: 10.21037/jtd-20-2740.

新兴癌症治疗时代的心房颤动 - Suppr | 超能文献

Atrial Fibrillation in the Era of Emerging Cancer Therapies.

作者信息

Guha Avirup, Dey Amit K, Jneid Hani, Ibarz Javier Pinilla, Addison Daniel, Fradley Michael

机构信息

National Heart, Lung and Blood Institute, NIH, Building 10-CRC Room 5-5232, Bethesda, MD, USA.

Division of Cardiology, Michael E. DeBakey VA Hospital, Baylor College of Medicine, Houston, TX, USA.

出版信息

Eur Heart J. 2019 Sep 21;40(36):3007-3010. doi: 10.1093/eurheartj/ehz649.

DOI:10.1093/eurheartj/ehz649

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6933869/

Abstract

摘要